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Abstract 
Bovine herpesvirus type 5 (BoHV-5) belongs to the family Herpesviridae, subfamily Alphaherpesvirinae, genus 
Varicellovirus. This virus is a major causative agent of non-suppurative meningoencephalitis in young cattle. It was 
first isolated in 1962 from a neurological disease outbreak in Australia. BoHV-5 is genetically and antigenically 
related to bovine herpesvirus type 1 (BoHV-1), a highly prevalent virus responsible for respiratory and genital 
disease in cattle. Initially, BoHV-5 was considered a subtype of BoHV-1 (BoHV-1.3). However, the exclusive 
presentation of outbreaks of neurological disease suggested that the virus was a new agent with characteristics of 
neuropathogenicity. Even though both are neurotropic viruses, only BoHV-5 is capable of replicating extensively in 
the central nervous system and inducing neurological disease. Occasionally, encephalitis caused by BoHV-1 has 
been reported. Like  other alpha-herpesviruses, BoHV-5 can establish  latency in  nervous  ganglia and, by  stress 
factors or glucocorticoid treatment, latent virus can be reactivated. During episodes of reactivation, the virus  is 
excreted in nasal, ocular and genital secretions and transmitted to other susceptible hosts. Recently, BoHV-5 has 
been associated with infection of the reproductive tract. The virus has been isolated and the presence of viral DNA 
has been demonstrated in semen samples from Brazil and Australia and natural transmission of the virus through 
contaminated  semen  has  also  been  described.  Embryos  and  oocytes  are  permissive  for  BoHV-5  infection  and 
BoHV-5 DNA has been detected in the central nervous system of aborted fetuses. The objective of this review is to 
compile the limited information on the recent association between BoHV-5 and reproductive disorders in cattle. 
Keywords: BoHV-5, Reproductive disorders, Semen. 
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Introduction 
Bovine  herpesvirus  type  5  (BoHV-5)  is  a  major 
causative  agent  of  non-suppurative 
meningoencephalitis  in  young  cattle  (Magyar  et  al., 
1993; Schwyzer and Ackermann, 1996; Pérez et al., 
2002; Delhon et al., 2003; Del Médico Zajac et al., 
2010).  The  virus  was  first  isolated  in  1962  from  a 
neurological disease outbreak in Australia (Johnston et 
al., 1962).  
Thereafter, the virus has been sporadically identified 
in  cases  of  meningoencephalitis  in  this  country 
(Studdert, 1989; Kirkland et al., 2009), in the United 
States (d´Offay et al., 1993; Ely et al., 1996) and in 
Europe  (Abdelmagid  et  al.,  1995).  However,  the 
disease  has  a  high  incidence  in  South  American 
countries, mainly in Central and Southern Brazil and 
Argentina (Pérez et al., 2002; Vogel et al., 2003). The 
reasons for this restricted geographical distribution of 
neurological cases are unknown.  
BoHV-5  is  genetically  and  antigenically  related  to 
bovine  herpesvirus  type  1  (BoHV-1),  a  virus 
responsible  for  a  variety  of  clinical  syndromes, 
including respiratory disease, conjunctivitis, abortion 
and genital infections (Tikoo et al., 1995; Jones and 
Chowdhury, 2007).  
After  natural  or  experimental  infections,  alpha-
herpesviruses  establish  latent  infections  in  sensory 
neurons  within  trigeminal  or  dorsal  root  ganglia 
(Stevens  and  Cook,  1971).  Viral  reactivation  from 
latency can occur naturally, by stress factors, or it can 
be  experimentally  induced  by  glucocorticoid 
administration.  During  episodes  of  reactivation,  the 
virus  is  re-excreted  in  nasal,  ocular  and  genital 
secretions  and  transmitted  to  other  susceptible  hosts http://www.openveterinaryjournal.com        
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(Rock et al., 1992). This is the main mechanism by 
which alpha-herpesviruses are maintained in nature.  
Initially,  BoHV-5  was  considered  a  subtype  of  
BoHV-1 (BoHV-1.3) (Engels et al., 1986; Metzler et 
al.,  1986;  Studdert,  1989).  However,  the  exclusive 
presentation  of  outbreaks  of  neurological  disease 
suggested  that  the  virus  was  a  new  agent  with 
characteristics  of  neuropathogenicity  (Moretti  et  al., 
1964; Watt et al., 1981; Weiblen et al., 1989).  
Both  BoHV-1  and  BoHV-5  are  neurotropic  viruses 
(Meyer et al., 2001; Pérez et al., 2002; Varela et al., 
2010). Nevertheless, both differ in the ability to cause 
encephalitis  (Ashbaugh  et  al.,  1997).  Even  though 
encephalitis  caused  by  BoHV-1  has  been  reported 
(Meyer  et  al.,  2001),  only  BoHV-5  is  capable  of 
extensive  replication  in  the  central  nervous  system 
(CNS) and production of neurological disease (Delhon 
et al., 2003).   
In 1992, the International Committee on Taxonomy of 
Viruses recognized BoHV-5 as a distinct virus from 
BoHV-1(Roizman, 1992; Pedraza and Alessi, 2004). 
The decision  was based on the results of restriction 
site  mapping  of  viral  DNA  (d´Offay  et  al.,  1993; 
Whetstone et al., 1993), cross-neutralization studies, 
and reactivity with monoclonal antibodies (Metzler et 
al., 1986; Collins et al., 1993).  
Presently,  strains  of  BoHV-5  are  designated  as 
subtypes  “a”,  “b”  and  “non  a-non  b”,  according  to 
restriction endonuclease patterns (D’Arce et al., 2002; 
Maidana  et  al.,  2011).    The  transient  presence  of 
subtype  “b”  strains  has  only  been  described  in 
Argentina.  Nevertheless,  in  this  country,  the  most 
common circulating BoHV-5 strains belong to subtype 
“a” (Maidana et al., 2011). 
Further studies are required to classify additional field 
strains  and  to  compare  with  the  profile  of  BoHV-5 
variants circulating in other countries. 
Properties of BoHV-5 
BoHV-5  belongs  to  the  family  Herpesviridae, 
subfamily  Alphaherpesvirinae,  genus  Varicellovirus. 
The  virion  is  enveloped  and  its  diameter  can  range 
from  120  to  250  nm,  containing  an  icosahedral 
nucleocapsid composed by 162 capsomers (Knowles, 
2011).  The  nucleocapsid  is  surrounded  by  a 
proteinaceous  layer,  called  tegument  (Thiry  et  al., 
2006).  
The  genome  consists  of  a  single  linear  molecule  of 
double-stranded DNA and it is classified as a type D 
genome, which consists of a unique long (UL) and a 
unique  short  (US)  region,  flanked  by  repeated 
sequences (Thiry et al., 2006). The genome of BoHV-
5 (138, 390 base pairs) is longer than BoHV-1genome 
and it contains 72 genes (Delhon et al., 2003). Both 
viruses  share  85%  genetic  similarity  (Chowdhury, 
1995)  and  approximately  82%  amino  acid  identity 
(Delhon et al., 2003).  
The  lytic  replicative  cycle  of  alpha-herpesviruses 
occurs  in  a  regulated  cascade.  A  virion  component 
activates  expression  of  immediate-early  (IE)  genes, 
which have regulatory roles in the activation of early 
(E) and late (L) genes. In latently infected neurons, the 
latency-related  (LR)  gene,  a  small  region  of  BoHV 
genome is abundantly transcribed (Rock et al., 1987; 
Kutish et al., 1990; Schang and Jones, 1997). BoHV-5 
-IE proteins (bICP0, bICP4 and bICP22) are the least 
conserved proteins. The LR gene, which has essential 
roles  in  the  latency-reactivation  cycle  of  alpha-
herpesviruses (Jones, 2003), differs markedly from its 
BoHV-1 counterpart (Delhon et al., 2003), suggesting 
that this condition may have important consequences 
on the in vivo virus pathogenesis. 
In cell cultures, BoHV-1 and BoHV-5 share similar 
morphology  and  cytopathic  effect.  Unlike  BoHV-1, 
BoHV-5 is difficult to isolate in cell culture (Carrillo, 
1982; Belknap et al., 1994; d´Offay et al., 1995; Ely et 
al.,  1996;  Cascio  et  al.,  1999),  even  from  animals 
experimentally  inoculated  and  showing  neurological 
signs. The difficulty in virus isolation has been related 
to the low viral titers in tissues samples (Belknap et 
al., 1994).  
Traditionally, BoHV-1 and BoHV-5 are differentiated 
based on the clinical features of the outbreaks and on 
DNA restriction profiles after virus isolation (Afonso 
et  al.,  2007).  More  recently,  the  development  of 
specific  PCR  techniques  has  allowed  the  precise 
differentiation of both viruses in clinical samples (van 
Engelenburg  et  al.,  1993,  1995;  Chowdhury,  1995; 
Diallo et al., 2010).  
Neurological disease associated with BoHV-5 
Outbreaks of meningoencephalitis caused by BoHV-5 
are commonly observed in South American countries 
(Pérez  et  al.,  2002;  Vogel  et  al.,  2003).  The 
prevalence of BoHV-5 is presently unknown, mainly 
because  of  the  serological  cross-reactivity  with 
BoHV-1(Vogel et al., 2002; Oldoni et al., 2004; Diel 
et al., 2007). 
The  first  outbreak  of  BoHV-5  in  Argentina  was 
described  in  1982  (Carrillo,  1982).  However,  in  a 
retrospective  study  of  Argentinean  cases  with 
histopathological diagnosis of cerebrocortical necrosis 
between  1970  and  1999,  Pérez  et  al.  (2003) 
demonstrated  by  in  situ  hybridization  that  BoHV-5 
DNA was present in some archival sections of neural 
tissues. Results from this study confirmed that BoHV-
5 was circulating in the country long before the virus 
was recognized as a causative agent of neurological 
disorder in cattle. 
BoHV-1 pathogenesis has been studied in detail and 
many  aspects  can  be  extrapolated  to  BoHV-5.  The 
respiratory tract is the main portal of entry of BoHV 
into  the  organism.  Initial  viral  replication  in  the 
epithelium  of  the  upper  respiratory  tract  and  in  the http://www.openveterinaryjournal.com        
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tonsils may lead to slight respiratory signs (Meyer et 
al., 2001; Vogel et al., 2004). Primary replication at 
the site of entry may last for 15 days (Vogel et al., 
2004).  In  the  case  of  BoHV-5,  after  replication  at 
mucosal sites, the virus reaches the CNS where viral 
replication causes neurological damage (Beltrão et al., 
2000, Meyer et al., 2001, Pérez et al., 2002).  
Two main routes have been described for the access of 
BoHV-5 to the CNS, 1) via the olfactory tract, through 
the terminals of the axons that innervate the olfactory 
mucosa (Nakazato et al., 2000; Pérez et al., 2002) and, 
2) via trigeminal nerve, reaching the sensory neurons 
of  trigeminal  ganglia  where  latency  is  established 
(Chowdhury et al., 1997; Lee et al., 1999; Coelho and 
Vidor, 2001; Pérez et al., 2002, 2005).  
Unlike BoHV-1, latency of BoHV-5 in other sites of 
CNS is also possible (Meyer et al., 2001). It has been 
suggested that viral reactivation from latency may lead 
to virus spread to different areas of the brain and this 
would  be  responsible  for  the  presence  of  mild 
neurological  signs  during  episodes  of  reactivation 
(Vogel et al., 2003). Neurological signs begin 9 to 10 
days  post-infection  and  they  include  tremors, 
depression,  opistothonus,  nystagmus,  teeth  gridding, 
circling and recumbency (Carrillo et al., 1983; Beltrão 
et al., 2000; Meyer et al., 2001, Pérez et al., 2002; 
Vogel et al., 2003). Signs are progressive and usually 
fatal  (Belknap  et  al.,  1994;  Beltrão  et  al.,  2000). 
BoHV-5 has been considered a classical neurotropic 
herpesvirus.   
However, Schudel et al. (1986) demonstrated that the 
virus was not restricted to the CNS of animals with 
clinical signs since the virus was isolated, in parallel, 
from  the  respiratory  tract.  Moreover,  in  this  study, 
BoHV-5 was recovered from an aborted fetus from a 
farm  in  which  sporadic  cases  of  abortion  were 
recorded but no cases of neurological disease had been 
observed. Thus, it is apparent that the virus it not only 
confined to the respiratory tract and CNS. This is the 
first presumptive association of BoHV-5 with clinical 
syndromes different from neurological disease.  
Genital disease associated with BoHV-1 and recent 
findings on reproductive disorders associated with 
BoHV-5 
BoHV-1  isolates  are  classified  into  two  subtypes; 
BoHV-1.1,  which  is  mainly  responsible  for  bovine 
infectious  rhinotracheitis,  and  BoHV-1.2,  which  is 
regularly  isolated  from  cases  of  genital  disease 
(Engels et al., 1986).  
The biological differences between subtypes are not 
clear. Although both  subtypes are able to infect  the 
respiratory and genital tracts, it is apparent that each 
genotype  has  specific  adaptations  for  growing  in 
particular  tissues.  Rijsewijk  et  al.  (1999)  suggested 
that differences in glycoprotein C may be responsible 
for the distinct phenotypes.  
Infections of the reproductive tract are usually caused 
and  disseminated  by  artificial  insemination  (AI) 
(Turin et al., 1999). Genital disorders associated with 
BoHV-1  include  pustular  balanoposthitis  and 
vulvovaginitis.  Balanoposthitis  is  usually 
accompanied  by  a  reduction  in  semen  quality  (van 
Oirschot, 1995). It is known that insemination of cows 
with  BoHV-1-contaminated  semen  can  also  cause 
abortion, infertility and endometritis (Elazhary et al., 
1980) and it has been demonstrated that the virus dose 
required to infect the cow via contaminated semen is 
extremely  low,  approximately  32  infectious  viral 
particles (Bielanski et al., 1988; Turin et al., 1999). 
Although abortions might occur as a consequence of 
genital  disease,  they  are  more  frequently  observed 
after  BoHV-1  respiratory  outbreaks  (Turin  et  al., 
1999).  
In the bull, the virus replicates in the mucosa of the 
prepuce, penis and urethra after entering the organism 
via  the  respiratory  or  genital  tract  (van  Oirschot, 
1995).  Contamination  of  the  semen  occurs  during 
ejaculation  from  virus  present  in  the  mucosa  of  the 
reproductive  tract  (van  Engelenburg  et  al.,  1995). 
Thus, BoHV-1 DNA is detected in the seminal fluid 
fraction (van Engelenburg et al., 1993; van Oirschot, 
1995).  
After genital infection, BoHV-1 establishes latency in 
sacral  ganglia  and  virus  reactivation  is  a  potential 
source  for  semen  contamination  (Ackermann  and 
Wyler,  1984).  It  is  well-established  that  BoHV-1-
latently  infected  cattle  can  excrete  virus, 
intermittently, in semen (van Engelenburg et al., 1993, 
1995).  Therefore,  sero-positive  bulls  should  not  be 
allowed  in  AI  centers.  Nevertheless,  Lemaire  et  al. 
(2000)  also  reported  the  existence  of  sero-negative 
latent carriers, which are an epidemiological threat for 
AI centers. Furthermore, BoHV-1 is detected in semen 
during primary infection, before the onset of clinical 
signs  (Weiblen  et  al.,  1992).  Therefore,  animals 
without  evidence  of  clinical  disease  are  also  a 
potential source of venereal virus transmission.  
Recently, there have been several reports describing 
the detection of BoHV-5 in bull semen. Gomes et al. 
(2003) showed that 6 out of 20 (30%) semen samples, 
previously  considered  positive  for  the  presence  of 
BoHV-1  were,  indeed,  BoHV-5-positive,  when  re-
evaluated by a BoHV-5-specific PCR.  
In Brazil, a semen sample from an apparently healthy 
bull, which was identified as BoHV-1-positive during 
virus  surveillance  at  an  AI  center  in  1996  was  re-
analyzed by Esteves et al. (2003). In this  work, the 
isolate  previously  characterized  as  BoHV-1  was  re-
classified as BoHV-5. The identity of the virus  was 
determined  by  the  use  of  BoHV-5-specific 
monoclonal antibodies in an immunoperoxidase assay 
and by a gC BoHV-1/5 PCR.  http://www.openveterinaryjournal.com        
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The first evidence of natural transmission of BoHV-5 
through  contaminated  semen  was  described  by 
Kirkland et al. (2009), in Australia. Later, in the same 
country, Diallo et al. (2010) isolated the virus from 
cryopreserved semen of a healthy bull. The identity of 
the  virus  was  confirmed  by  PCR  and  by  direct 
amplicon  sequencing,  demonstrating  the  importance 
of  using  molecular  techniques  for  the  detection  of 
viral agents in semen samples. In Brazil, Oliveira et 
al.  (2011)  used  a  two  species-specific  nested  PCR 
which  differentiates  BoHV-1  and  BoHV-5  and  they 
identified  BoHV-5  DNA  in  100%  (76/76)  semen 
samples.  Additionally,  in  44.7%  (34/76)  samples, 
BoHV-1 DNA was also present.  
Kirkland  et  al.  (2009)  described  an  outbreak  of 
vulvovaginitis  with  clinical  signs  and  gross  lesions 
identical  to  those  caused  by  BoHV-1.  After  virus 
isolation,  BoHV-1  was  considered  the  presumptive 
causal  agent  of  the  genital  infection.  Later,  by 
restriction  enzyme  analysis  and  quantitative  PCR  it 
was determined that BoHV-5 was the virus detected in 
the semen of the bull used for AI. Therefore, it was 
suggested  that  BoHV-5  was  responsible  for  the 
outbreak  of  vulvovaginitis  previously  attributed  to 
BoHV-1. 
Silva-Frade et al. (2010b) documented the detection of 
BoHV-5  DNA  in  the  acrosomal  region  and  tail  of 
spermatozoids  experimentally  exposed  to  the  virus. 
Nevertheless, it has not been elucidated whether the 
virus infects the spermatozoid or it is attached to its 
surface. Among the sperm parameters, the velocity of 
spermatozoid progression seems to be reduced and a 
low  level  of  apoptosis,  without  affecting  the  total 
quality of the sperm, has also been reported (Souza et 
al., 2011). Apparently, unlike BoHV-1 (Tanghe et al., 
2005),  experimental  BoHV-5  infection  of 
spermatozoids  does  not  interfere  with  in  vitro 
fertilization  or  embryo  development  (Souza  et  al., 
2011).  
Silva-Frade et al. (2010a) demonstrated that oocytes 
and  embryos  were  infected  by  BoHV-5  when 
experimentally  exposed  to  the  virus.  By  in  situ 
hybridization it was shown that the virus was present 
in the cumulus cells of the oocytes and in the inner 
cells of the embryos. BoHV-5 decreased the cleavage 
rate of oocytes only when they were grown in medium 
containing  fetal  bovine  serum.  However,  adverse 
effects  were  not  observed  when  polyvinyl  alcohol 
medium was used. Thus, the effect on cleavage rate 
seems to be dependent on other conditions rather than 
BoHV-5 infection alone. Viral replication in oocytes 
and embryos was proved by an increase in virus titers 
from  an  inoculation  dose  of  10
2.3  TCID50/50μl  to 
10
5.3TCID50/50μl at the  embryo stage (Silva-Frade et 
al.,  2010b),  demonstrating  that  these  cells  are 
permissive for BoHV-5 infection. 
Abortions  are  a  common  sequel  of  BoHV-1- 
respiratory infection. However, the role of BoHV-5 in 
abortion  has  not  been  definitively  demonstrated. 
Recently, in Argentina, Marin et al. (2011) identified 
BoHV-5 in the CNS of aborted fetuses. Virus isolation 
from  fetal  spleen  and  brain  on  MDBK  cells,  a 
multiplex PCR and seroneutralization tests for BoHV-
1  and  5  were  carried  out.  BoHV  was  not  isolated. 
Nevertheless, BoHV-5 DNA-specific sequences were 
detected in fetal nervous tissue by multiplex PCR and 
confirmed  by  sequencing  of  PCR  products.  The 
presence  of  BoHV-5  DNA  in  aborted  fetal  nervous 
system  is  the  first  description  of  this  virus  in 
association with bovine abortion.  
The  use  of  molecular  biology  techniques  for  the 
identification of BoHV-5 in this study was essential to 
improve the sensitivity of the diagnosis of infectious 
causes of bovine abortion, especially when autolysis 
was present. It also allowed the differentiation of the 
type  of  BoHV  involved.  Although  virus  DNA 
detection does not prove BoHV-5 is responsible for 
the abortion, its presence in fetal tissues is suggestive 
of its involvement.  
Many  aspects  of  BoHV-5  association  with  genital 
disease remain to be elucidated. It is likely that the 
pathogenesis  of  this  disorder  is  similar  to  that  of 
BoHV-1.  
However, further studies are required to establish the 
role of the virus in the infection of the reproductive 
tract. Furthermore, other issues need to be addressed. 
For example, it has not been established whether the 
infection of a cow with contaminated semen can lead 
to a latent infection or whether infection by this route 
can cause neurological disease.  
Batches of frozen semen from bulls of accredited AI 
centers  are  normally  certified  negative  for  acute 
epidemic diseases.  
Presently, an increasing number of these centers are 
also certified negative for viruses like bovine leukemia 
virus (BLV), BoHV-1 and bovine viral diarrhea virus 
(BVDV) (Wrathall et al., 2006). The precise role of 
BoHV-5 in reproductive disease of cattle is still under 
study.  However,  the  sole  presence  of  the  virus  in 
bovine semen should be considered as a threat for the 
international trade of frozen semen. As a consequence, 
detection  of  BoHV-5  should  be  included  in  the 
pathogen screening policies of AI centers. 
Conclusion 
For  decades,  BoHV-5  has  been  considered  a  viral 
agent with exclusive tropism for the CNS. However, 
recent  reports  have  involved  BoHV-5  in  the 
development of genital disease. Presently, the studies 
on the role of BoHV-5 in diseases of the reproductive 
tract are not conclusive.  
However, there are many evidences that demonstrate 
that the virus is a potential threat for AI centers since http://www.openveterinaryjournal.com        
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it is excreted in semen and  it can be transmitted to 
susceptible cows. To prevent the spread of the virus 
by  AI, all semen  samples, even those of apparently 
healthy bulls, should be analyzed. Further studies are 
required  to  establish  the  precise  role  of  BoHV-5  in 
bovine  abortion  and  other  conditions  of  the  genital 
tract. 
Furthermore, this review highlights the importance of 
the application of molecular biology techniques for the 
characterization  and  differentiation  of  bovine 
herpesviruses in clinical samples. 
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